Food producer Kirin and Meiji University have developed a pair of chopsticks that stimulate the taste of salt in foods with low salt content through extensive research.
This technology, which has yet to be named, accomplishes this by merely injecting a weak electric current into your food.
The difficulty was to find just the correct electrical waveform to impact the ions that are responsible for salty tastes, such as sodium chloride, such that the saltiness they create is increased.
Additionally, the ions in monosodium glutamate, which is responsible for the umami flavor of meals like miso soup, are affected by this current.
To establish a benchmark, the researchers fed patients a gel with a specific salt concentration and asked them to rate how salty it tasted.
They next gave them a gel with 30 percent less salt. Interestingly, the test respondents' ratings also revealed a surprisingly accurate decline in perceived saltiness of roughly 30%.
Tests with a low-salt miso soup yielded encouraging results, with observations that not only saltiness but also umami and overall flavor, were improved.


Tabletop particle accelerator could transform medicine and materials science
NASA Partners with Katalyst to Save Swift Observatory with Innovative Docking Mission
Citi Sets Bullish 2026 Target for STOXX 600 as Fiscal Support and Monetary Easing Boost Outlook
U.S. Reveals 2026 Medicare Star Ratings: Aetna, UnitedHealth Lead in Quality Scores
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
CDC Shake-Up Sparks Vaccine Policy Clash Between RFK Jr. and Susan Monarez
Lab-grown meat: you may find it icky, but it could drive forward medical research
YouTube Agrees to Follow Australia’s New Under-16 Social Media Ban
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
Amazon Italy Pays €180M in Compensation as Delivery Staff Probe Ends
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease
Netflix’s Bid for Warner Bros Discovery Aims to Cut Streaming Costs and Reshape the Industry
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Pfizer Secures $10 Billion Deal for Obesity Drug Developer Metsera, Outbids Novo Nordisk
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Visa to Move European Headquarters to London’s Canary Wharf 



